|
|||||
|
|
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer |
|
| Authors: | Young Kwang Chae Andrew A. Davis Sarita Agte Alan Pan Nicholas I. Simon Wade T. Iams Marcelo R. Cruz Keerthi Tamragouri Kyunghoon Rhee Nisha Mohindra Victoria Villaflor Wungki Park Gilberto Lopes Francis J. Giles |
| Affiliation: | 1. Developmental Therapeutics Program of Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA;2. Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA;3. Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA;4. Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA;5. Developmental Therapeutics Program of Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA;6. Developmental Therapeutics Program of Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA;7. Division of Hematology and Medical Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida, USA |
| Abstract: | |
| Keywords: | Circulating tumor DNA (ctDNA) Tumor mutational burden (TMB) NSCLC PD-1 PD-L1 |